Intravascular Immunoglobulin (IVIG) Administration

Preparations of intravascular immunoglobulin are the preparations that include donor antibodies obtained from a great number of donors. Usually, it is given in dose of 400-600 mg/kg in 3-4 weeks at intervals, it can be used also in lower or higher doses. The treatment which is required for certain disease groups enables the infection frequency/severity to be decreased in these disease groups. It cannot normalize the current sequela changes of tissues and organs of patients in long-term untreated follow up, however it prevents the new sequelae to develop.

The patient is followed up closely during infusion in accordance with adverse effects, the infusion is interrupted if allergic reactions such as shivering, fever, bruising, rash, respiratory distress, intense pain are observed in patient while the medication is given, and medical treatment is applied.